Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - busulfan, quantity: 2 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; magnesium stearate; lactose; titanium dioxide; hypromellose; triacetin - indications as at 10 february 2005: treatment of chronic granulocytic leukaemia. it has been shown to be superior to splenic irradiation when judged by survival times, control of spleen size and maintenance of haemoglobin levels. although not curative, busulfan reduces the total granulocyte mass, relieves disease symptoms and improves the clinical state of the patient. busulfan is not useful once blast transformation has occurred. busulfan produces prolonged remission in polycythaemia vera. it is especially useful in cases resistant to radiophosphorus (32 p) and where there is marked thrombocytosis. busulfan is useful in selected cases of essential thrombocythaemia and myelofibrosis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid, solution - excipient ingredients: hyetellose; glycerol; sorbitol solution (70 per cent) (crystallising); purified water; polysorbate 20; menthol; methyl hydroxybenzoate; citric acid; flavour - helps break down mucus and helps clear the chest in conditions accompanied by excessive mucus secretions such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - bromhexine hydrochloride, quantity: 8 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; maize starch; povidone; magnesium stearate; colloidal anhydrous silica - mucolytic. breaks down mucus and helps clear chest congestion.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - bromhexine hydrochloride, quantity: 1.6 mg/ml - oral liquid - excipient ingredients: menthol; glycerol; sodium benzoate; hyetellose; polysorbate 20; sorbitol solution (70 per cent) (crystallising); citric acid; sucralose; flavour - mucolytic. breaks down mucus and helps clear chest congestion.

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - bromhexine hydrochloride - unknown - bromhexine hydrochloride guanidine active 0.0 - active constituent

Nova Zelanda - anglès - Ministry for Primary Industries

randlab australia pty limited - sulphadimidine; bromhexine hydrochloride; trimethoprim - sulphadimidine 430 g/kg; bromhexine hydrochloride 8.6 g/kg; trimethoprim 86 g/kg - antibiotic

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - bromhexine hydrochloride,guaifenesin -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - bromhexine hydrochloride -